Product Information
- 1-[(6-Chloroimidazo[2,1-b]thiazol-5-yl)sulfonyl]-1H-indole-3-ethanamine
- 2-[1-(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonylindol-3-yl]ethanamine
- 2-[1-[(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonyl]-1H-indol-3-yl]ethylamine
- 1H-Indole-3-ethanamine, 1-[(6-chloroimidazo[2,1-b]thiazol-5-yl)sulfonyl]-
WAY 181187 is a specific agonist of the 5-HT6 receptor. It has been shown to inhibit the signal pathways and locomotor activity in rats, and has cancer-inhibiting effects. WAY 181187 has also been shown to be an inhibitor of 5-HT6 receptors, which are involved in the transmission of serotonin signals. 5-HT6 receptors are located primarily on neurons in the brain that control locomotion, mood, anxiety and appetite. They have also been implicated as a potential target for treatment of depression and anxiety disorders. WAY 181187 is structurally similar to a serotonin molecule with an oxygen atom replaced by sulfur (5-ht). The tautomeric form of this molecule is a 5-ht agonist. This drug inhibits glutamate from binding to its receptors on neuronal cells and appears to have electrophysiological properties that are different from other drugs used for the treatment of Parkinson's disease.
Chemical properties
Technical inquiry about: 3D-EXA40349 WAY 181187
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
